AHR and inflammatory bowel disease: This appears to be the case of IBD, in which the reduced expression of AHR in epithelial and immune cells contributes to promoting several pathways that alter the epithelial barrier integrity, expand the effector cytokine response, and block the function of anti-inflammatory molecules.